Exome sequencing in tracking clonal evolution in multiple myeloma following therapy (Q48754565)

15 February 2018

title

Exome sequencing in tracking clonal evolution in multiple myeloma following therapy (English)

1 reference

15 February 2018

1 reference

15 February 2018

S Pfeifer

0 references

N Weston-Bell

1 reference

15 February 2018

J Gibson

1 reference

15 February 2018

M John

1 reference

15 February 2018

S Ennis

1 reference

15 February 2018

T Cezard

1 reference

15 February 2018

H Ludwig

1 reference

15 February 2018

N Zojer

1 reference

15 February 2018

S S Sahota

1 reference

15 February 2018

publication date

9 October 2012

1 reference

15 February 2018

published in

Leukemia

1 reference

15 February 2018

volume

1 reference

15 February 2018

issue

1 reference

15 February 2018

page(s)

1188-1191

1 reference

15 February 2018

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Many multiple myelomas: making more of the molecular mayhem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transpla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Initial genome sequencing and analysis of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Clonal competition with alternating dominance in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Combinatorial drug therapy for cancer in the post-genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Detecting false-positive signals in exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.287

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2012.287

1 reference

15 February 2018

1 reference

15 February 2018